Related Experiment Video
Updated: Dec 29, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Scrofula Caused by Multidrug-Resistant Tuberculosis
Bárbara Pedro1, Liliana Alves2, Rita Magano2
1Serviço de Medicina II, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal.
This case study highlights a rare instance of multidrug-resistant tuberculosis (MDR-TB) lymphadenitis in an HIV-negative individual. Enhanced surveillance is crucial for controlling the global burden of this serious infectious disease.
Area of Science:
- Infectious Diseases
- Public Health
- Clinical Case Study
Background:
- Tuberculosis (TB) remains a leading global cause of mortality, with multidrug-resistant tuberculosis (MDR-TB) posing a significant challenge.
- MDR-TB is defined by resistance to at least isoniazid and rifampin, key anti-TB drugs.
- Preventing new Mycobacterium tuberculosis infections and disease progression is vital for reducing TB's global impact.
Purpose of the Study:
- To report a rare case of MDR-TB presenting as cervical lymphadenopathy in an HIV-negative patient.
- To underscore the importance of recognizing uncommon manifestations of MDR-TB.
- To emphasize the need for intensified disease surveillance for effective TB control.
Main Methods:
- Case presentation of a 73-year-old HIV-negative female.
- Clinical evaluation including assessment of cervical lymphadenopathy.
- Diagnosis of multidrug-resistant tuberculosis (MDR-TB).
Main Results:
- The patient was diagnosed with MDR-TB.
- The presentation involved cervical lymphadenopathy, a rare manifestation of MDR-TB.
- This case occurred in Portugal, highlighting regional variations in disease presentation.
Conclusions:
- Multidrug-resistant tuberculosis lymphadenitis is an uncommon clinical presentation, particularly in HIV-negative individuals.
- Effective national and global TB control requires intensified government surveillance strategies.
- Focusing on prevention remains paramount in combating the ongoing threat of tuberculosis worldwide.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...